Effects of omega-3 administration on homocysteine serum concentration in renal transplant recipient.

Background: It has been shown that serum total homocysteine (HC) is a risk factor for vascular disease which characterizes endothelial damage in the general and in the End-Stage Renal Disease (ESRD) population as well. Whether n-3 polyunsaturated fatty acids decrease homocysteine (Hcy) level has been a subject of controversy. Methods: Renal transplant patients were randomized in 2 groups and received 6 months of dietary supplementation with 6 g/day of Fish oil or placebo. Homocysteine level and total cholesterol level were measured. Results: In 40 renal transplant recipients , increase in homocysteine level was greater after Fish oil administration but not significantly, total cholesterol was decreased significantly. Conclusion: Based on these data omega3 fatty acids supplementation doesn’t decrease serum homocysteine in renal transplant recipients but decreases total cholesterol level.

[1]  G. Danovitch,et al.  CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Is There a Reversal of Reverse Epidemiology in Renal Transplant Recipients? , 2007, Seminars in dialysis.

[2]  A. Wierzbicki,et al.  Homocysteine and cardiovascular disease: a review of the evidence , 2007, Diabetes & vascular disease research.

[3]  A. Fazelzadeh,et al.  How to decrease cardiovascular mortality in renal transplant recipients. , 2006, Transplantation proceedings.

[4]  R. Montañés,et al.  Factors involved in baseline hyperhomocysteinemia in renal transplantation. , 2005, Transplantation proceedings.

[5]  Xiao-feng Wang,et al.  Treatment of hyperhomocysteinemia and endothelial dysfunction in renal transplant recipients with B vitamins in the Chinese population. , 2008, The Journal of urology.

[6]  K. Mccully,et al.  Fish oil decreases serum homocysteine in hyperlipemic men , 1993, Coronary artery disease.

[7]  D. Nilsen,et al.  Reduction in Homocysteine by n–3 Polyunsaturated Fatty Acids after 1 Year in a Randomised Double-Blind Study following an Acute Myocardial Infarction: No Effect on Endothelial Adhesion Properties , 2003, Pathophysiology of Haemostasis and Thrombosis.

[8]  D. Grekas,et al.  Combined Treatment with Low-Dose Pravastatin and Fish Oil in Post-Renal Transplantation Dislipidemia , 2001, Nephron.

[9]  J. Baltar,et al.  Risk factors for cardiovascular disease during the first 2 years after renal transplantation. , 2005, Transplantation proceedings.

[10]  J. Davignon,et al.  Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health. , 2003, The Journal of laboratory and clinical medicine.

[11]  S. Hausmann,et al.  Increased Serum Level of Total Homocysteine in Capd Patients despite Fish Oil Therapy , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[12]  W. Winkelmayer,et al.  Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. , 2004, Journal of the American Society of Nephrology.

[13]  D. Nilsen,et al.  Atherothrombogenic Risk Modulation by n-3 Fatty Acids Was not Associated with Changes in Homocysteine in Subjects with Combined Hyperlipidaemia , 1999, Thrombosis and Haemostasis.

[14]  E. Salido,et al.  Dietary fish oil does not influence acute rejection rate and graft survival after renal transplantation: a randomized placebo-controlled study. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  Wang Xiaofeng,et al.  Treatment of Hyperhomocysteinemia and Endothelial Dysfunction in Renal Transplant Recipients With B Vitamins in the Chinese Population , 2008 .

[16]  D. Saitovitch,et al.  Serum homocysteine levels in renal transplant recipients with and without hypercholesterolemia. , 2007, Arquivos brasileiros de cardiologia.

[17]  J. Gavira,et al.  Preliminary results of the effect of treatment of hyperhomocysteinemia and its relationship with inflammation, coagulation status, and endothelial function after renal transplantation. , 2005, Transplantation proceedings.

[18]  Daniel P Beavers,et al.  Omega‐3 fatty acid supplementation and total homocysteine levels in end‐stage renal disease patients , 2008, Nephrology.

[19]  R. Abbate,et al.  Homocysteine-lowering therapy and carotid intima-media thickness in renal transplant recipients. , 2005, Transplantation proceedings.

[20]  J. Pimentel,et al.  Therapy of post-renal transplantation hyperlipidaemia: comparative study with simvastatin and fish oil. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  A. Žák,et al.  [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination]. , 2005, Casopis lekaru ceskych.